Danaher Corp.

NYSE:DHR   3:59:58 PM EDT
257.91
-1.12 (-0.43%)
4:00:00 PM EDT: $257.93 +0.02 (+0.01%)
Products

Beckman Coulter's Sars-Cov-2 IgG II Antibody Test Receives Emergency Use Authorization From FDA

Published: 03/23/2021 18:01 GMT
Danaher Corp. (DHR) - Beckman Coulter's Sars-cov-2 Igg Ii Antibody Test Receives Emergency Use Authorization From the FDA.
Beckman Coulter - Assay Available to Ship in U.S. and Countries Accepting Ce Mark.